Because the endocrine disruption hypothesis suggests that the fetus and newborns could be vulnerable to BPA in ways children or adults would not be, the focus of these PK studies has been on the perinatal period.
FORBES: Leading Environmental Group Scientist Praises FDA's Ground-Breaking Research On BPA: A Tipping Point In The Controversy?